Ribatrial.com Clinic Trial - Ribavirin
Today is:
ribatrial Clinic Trial Ribavirin
Home - Ribatrial.com
ribatrial.com ribavirin clinical trials
About Ribatrial.com
ribatrial.com ribavirin clinical trials
Trial FAQ
ribatrial.com ribavirin clinical trials
The Ribatrial.com
ribatrial.com ribavirin clinical trials
ribatrial.com ribavirin clinical trials
ribatrial.com ribavirin clinical trials
Log In
Ribatrial.com Clinical Trial - Ribavirin

Canada-wide translational research initiative supported by Leukemia and Lymphoma Society

Our initial goal was to determine the efficacy of the use of ribavirin as a treatment for specific subtypes of acute myeloid leukemia (FAB subtypes M4 and M5). Ribavirin has been used extensively as a broad spectrum anti-viral therapy. Thanks to support of The Leukemia and Lymphoma Society (USA), we tested the efficacy of ribavirin treatment in the patients in a Canada-wide clinical trial. We observed striking improvement with our patients, however, all eventually developed resistance to ribavirin (Assouline et al., Blood, 2009). In a second trial funded by the Leukemia and Lymphoma Society, we will test the efficacy of the combination of ribavirin with low dose Ara-C. In this way, we hope to overcome the resistance we observed when using ribavirin alone.

The group of investigators involved in this trial have a broad spectrum of expertise. The clinical trial and support team has extensive experience in the development and execution of clinical studies in hematology-oncology. Paralleling the clinical work, are basic science studies that will help with the development of future treatment modalities based on ribavirin and the findings of this study.


Physician and Researcher Log In
Log in to Ribatrial.com
Copyright© Ribaltrial.com 2006. All Rights Reserved.
Montreal Web Design Company Saffronweb.com